Effect of mangiferin on mitochondrial energy production in experimentally induced myocardial infarcted rats
Abstract
Mangiferin, from the leaves of Mangifera indica Linn., has been suggested as useful in the treatment of cardiovascular disorders. In the present study this drug was examined on the alteration of cardiac energy metabolism in isoproterenol (ISPH) administered myocardial infarcted rats. ISPH (20 mg/kg b.w.), which was administered s.c. twice at an interval of 24 h, caused a significant decrease in the activities of TCA cycle enzymes and antioxidant defense enzymes with a concomitant increase in the lipid peroxidation of heart mitochondria in rat model. The ATP production and the oxidation of succinate in State 3 and 4 decreased significantly in the cardiac mitochondria of ISPH administered rats. These functional alterations were supported by severe modifications in mitochondrial ultrastructure. Pretreatment with mangiferin (100 mg/kg b.w. i.p.) for 28 days prevented these mitochondrial alterations, oxidation with energy metabolism and restored the TCA cycle enzyme activities to near normal values following ISPH administration. The structural integrity of the heart was protected by mangiferin in ISPH administered rats when compared to the untreated controls. The present findings suggest that the protective effect of mangiferin can be attributed to its reducing effect on oxidative damage and activation of mitochondrial energy metabolism. These results could be useful to study and understand the cellular events involved in this cardioprotective mechanism of mangiferin. Our studies…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In myocardial cells under ISPH-induced MI, mangiferin protects structural integrity by reducing oxidative damage and increasing mitochondrial energy metabolism.
“In addition, studies in myocardial cells under the condition of ISPH-induced MI demonstrated mangiferin protects the structural integrity of by reducing the effects of oxidative damage and increasing mitochondrial energy metabolism (78).”
From Mangiferin: An effective therapeutic agent against several disorders (Review) (2018) · cites this paper as [78]
Mangiferin markedly increases activities of the tricarboxylic acid cycle and antioxidant defense enzymes in MI.
“Mangiferin markedly increases the activities of the tricarboxylic acid cycle and antioxidant defense enzymes in MI (78).”
From Mangiferin: An effective therapeutic agent against several disorders (Review) (2018) · cites this paper as [78]
Cited by
Sorted by citations
Mangiferin: A xanthonoid with multipotent anti‐inflammatory potential
Saha, S., Sadhukhan, P., & Sil, P. C. (2016) · BioFactors · doi:10.1002/biof.1292 · Cited by 159 · see citing works
Mangiferin: An effective therapeutic agent against several disorders (Review)
Du, S., Liu, H., Lei, T., Xie, X., Wang, H., He, X., Tong, R., & Wang, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9529 · Cited by 139 · see citing works
“Mangiferin markedly increases the activities of the tricarboxylic acid cycle and antioxidant defense enzymes in MI (78).”
Morozkina, S. N., Nhung Vu, T. H., Generalova, Y. E., Snetkov, P. P., & Uspenskaya, M. V. (2021) · Biomolecules · doi:10.3390/biom11010079 · Cited by 82 · see citing works
Pinneo, S., O'Mealy, C., Rosas Jr., M., Tsang, M., Liu, C., Kern, M., Hooshmand, S., & Hong, M. Y. (2022) · Journal of Medicinal Food · doi:10.1089/jmf.2021.0063 · Cited by 19 · see citing works
- Authors
- Prabhu, S., Jainu, M., Sabitha, K. E., & Shyamala Devi, C. S.
- Affiliations
- University of Madras (IN)
- ORCID
- Prabhu, S.
- Venue
- Vascular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 44
- Issue
- 6
- Pages
- 519-525
- ISSN
- 1537-1891 (ISSN-L)
- OpenAlex
- W2085270777
- Cited by
- 68
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2022: 1 · 2021: 5 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 6 · 2015: 1 · 2014: 4 · 2013: 5 · 2012: 6
- FWCI
- 14.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Vascular Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Council of Scientific and Industrial Research, India
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Mangiferin and Mango Extracts
- Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- mangiferin, mango, myocardial infarction, isoproterenol-induced cardiotoxicity, myocardial energy metabolism, mitochondrial energy production, TCA cycle enzymes, lipid peroxidation, antioxidant enzymes, mitochondrial ultrastructure, cardioprotection, oxidative damage, succinate oxidation
- MeSH terms
- Animals, Antioxidants, Blood Glucose, Disease Models, Animal, Energy Metabolism, Glutathione, Isoproterenol, Male, Mitochondria, Heart, Myocardial Infarction, NAD, NADH Dehydrogenase, Succinate Dehydrogenase, Lipid Peroxidation, Rats, Wistar, Succinic Acid, Xanthones, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review